Menu

Study: Infants’ Brain Activity Patterns Predict Autism Risk

Scientists provide evidence that blood-flow patterns in six-month-old babies’ brains can accurately predict cognitive and behavioral markers of autism spectrum disorder two years later.  

Jun 8, 2017
Aggie Mika

PIXABAY, BRIEFKASTEN2

  Using functional magnetic resonance imaging (fMRI), researchers demonstrated that six-month-old infants previously identified as high risk for autism spectrum disorder (ASD) displayed brain activity patterns that predicted their future diagnosis with the condition, according to a report published today (June 7) in Science Translational Medicine.

In a collaborative effort, scientists at the University of North Carolina at Chapel Hill and Washington University School of Medicine scanned the brains of 59 sleeping infants using fMRI—a non-invasive imaging technique that picks up on changes in brain function based on fluctuations in blood flow throughout the brain. The babies included in the study had siblings already diagnosed with ASD. According to Spectrum, infants with older ASD siblings have “about a 20-fold increase in autism risk compared with the general population.”

When the kids in the study reached two years of age, the researchers assessed their sociability, language and motor development, ability to communicate, and propensity to engage in ASD-like repetitive behavior. At this time, 11 out of the 59 toddlers had been diagnosed with ASD. The researchers asked if the activity patterns in functionally connected brain regions at six months could identify which toddlers would display cognitive and behavioral traits indicative of an ASD diagnosis—the researchers refer to this in their study as “a research clinical best-estimate diagnosis of ASD.”

The researchers found that babies’ brain activity patterns indeed correlated with repetitive and social behavior as well as motor and language abilities later in life. Using a machine learning algorithm, the scientists demonstrated that brain activity in early life correctly predicted an ASD diagnosis in nine out of 11 babies, and correctly predicted the lack of ASD in all 48 infants who did not receive a diagnosis.

According to the National Institute of Child Health and Human Development (NICHD), typical ASD symptoms include problems with "communication and interactions with other people" and engaging in "routines or repetitive behaviors."

Doctors are seldom able to diagnose ASD prior to two years of age because “behavioral characteristics of ASD generally unfold during the second year of life, typically showing consolidation of the full behavioral syndrome by about 24 months of age,” the authors write in the report.

“Autism is defined as a collection of behaviors, but infants don’t really have those behaviors,” lead author Robert Emerson of the University of North Carolina at Chapel Hill tells Spectrum. “What we’ve gone to look for is the foundations in the brain that set those behaviors up in the future.”

“Although the findings are early-stage, the study suggests that in the future, neuroimaging may be a useful tool to diagnose autism or help health care providers evaluate a child’s risk of developing the disorder,” says National Institute of Mental Health (NIMH) director Joshua Gordon in a news release.

Gordon is not listed as an author on the report. The authors were funded by NIMH and NICHD. 

November 2018

Intelligent Science

Wrapping our heads around human smarts

Marketplace

Sponsored Product Updates

Slice® Safety Cutters for Lab Work

Slice® Safety Cutters for Lab Work

Slice cutting tools—which feature our patent-pending safety blades—meet many lab-specific requirements. Our scalpels and craft knives are well suited for delicate work, and our utility knives are good for general use.

The Lab of the Future: Alinity Poised to Reinvent Clinical Diagnostic Testing and Help Improve Healthcare

The Lab of the Future: Alinity Poised to Reinvent Clinical Diagnostic Testing and Help Improve Healthcare

Every minute counts when waiting for accurate diagnostic test results to guide critical care decisions, making today's clinical lab more important than ever. In fact, nearly 70 percent of critical care decisions are driven by a diagnostic test.

LGC announces new, integrated, global portfolio brand, Biosearch Technologies, representing genomic tools for mission critical customer applications

LGC announces new, integrated, global portfolio brand, Biosearch Technologies, representing genomic tools for mission critical customer applications

LGC’s Genomics division announced it is transforming its branding under LGC, Biosearch Technologies, a unified portfolio brand integrating optimised genomic analysis technologies and tools to accelerate scientific outcomes.